/

Empresas

Ne

No verificado

Neuraptive Therapeutics, Inc.

Sobre qué escribimos

BiotecnologíaFarmacéuticaHigiene alimentariaIndustriaSalud

3 Comunicados de prensa

Ver todos los comunicados de prensa

14/07/2026

Mercado laboral

Industria

Material médico sanitario

Salud

Sanidad

Farmacéutica

Biotecnología

Neuraptive Therapeutics Licenses Innovative Bioresorbable Nerve Stimulation Technology from Washington University in St. Louis

Fuente

Neuraptive Therapeutics, Inc.

Editor

1.00

0

02/10/2025

Ciencia

Higiene alimentaria

Medicina - Varios

Biotecnología

Salud

Farmacéutica

Defensa/Fuerzas Armadas

Industria

Neuraptive Therapeutics, Inc. Announces First Patient Enrolled in Phase 3 Clinical Trial Evaluating the Safety and Efficacy of NTX-001 Compared to Standard of Care in the Treatment of Upper Extremity Transected Nerves Requiring Surgical Repair

Fuente

Neuraptive Therapeutics, Inc.

Editor

1.00

0

11/09/2024

Neuraptive Therapeutics Receives FDA Breakthrough Therapy Designation for NTX-001 and Provides Update on the Advancements of NTX-001 for the Treatment of Peripheral Nerve Injury Requiring Repair

Fuente

Neuraptive Therapeutics, Inc.

Editor

1.00

0

Seguidores

0

Compatibilidad

0